Aberrant FGF-2, FGF-3, FGF-4 and C-ERB-B2 Gene Copy Number in Human Ovarian, Breast and Endometrial Tumours

References

• Adnane J., Gaudray P., Simon M. P., Simony-Lafontaine J., Jeanteur P., Theillet C. Proto-oncogene amplification and human breast tumour phenotype. Oncogene 1989; 4: 1389–1395
   PubMed Web of Science ®Google Scholar
• Ali I. U., Campbell G., Lidereau R., Callahan R. Lack of evidence for the prognostic significance of c-erb-B2 amplification in human breast carcinoma. Oncogene Res. 1988; 3: 139–146
   PubMedGoogle Scholar
• Asakawa J., Satoh C., Yamasaki Y., Chen S. H. Accurate and rapid detection of heterozygous carriers of a deletion by combined polymerase chain reaction and high performance liquid chromatography. Proc. Natl Acad. Sci. USA 1992; 89: 9126–9130
   PubMed Web of Science ®Google Scholar
• Baird A., Esch F., Mormede P., Ueno N., Ling N., Bohlen P., Ying S. Y., Wehrenberg W. B., Guillemin R. Molecular characterisation of fibroblast growth factor: distribution and biological activities in various tissues. Recent Prog. Horm. Res. 1986; 42: 143–205
   PubMedGoogle Scholar
• Bhattacharyya G. K., Johnson R. A. Statistical concepts and methods. John Wiley and Sons, New York, Chichester, Brisbane, Toronto, Singapore 1977
   Google Scholar
• Berger M. S., Locher G. W., Saurer S., Gullick W. J., Waterfield M. D., Groner B., Hynes N. E. Correlation of c-erb-B2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res. 1988; 48: 1238–1243
   PubMed Web of Science ®Google Scholar
• Bianchi A. B., Navone N. M., Conti C. J. Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumour specimens by the polymerase chain reaction. Am. J. Path. 1991; 138: 279–284
   PubMed Web of Science ®Google Scholar
• Bishop J. M. Molecular themes in oncogenesis. Cell 1991; 64: 235–248
   PubMed Web of Science ®Google Scholar
• Boyd J., Risinger J. I. Analysis of oncogene alterations in human endometrial carcinoma: prevalence of ras mutations. Mol. Carcinog. 1991; 4: 189–195
   PubMed Web of Science ®Google Scholar
• Cooper G. M. Oncogenes as markers for early detection of cancer. J. Cell. Biochem. 1992; 16: 131–136
   Google Scholar
• Csokay B., Papp J., Besznyak I., Bosze Sarosi Z., Toth J., Zalay Z., Olah E. Oncogene patterns in breast and ovarian carcinomas. Eur. J. Surg. Oncol. 1993; 19: 593–599
   PubMedGoogle Scholar
• Descotes F., Pavy J. J., Adessi G. L. Human breast cancer: correlation study between HER-2/neu amplification and prognostic factors in an unselected population. Anticancer Res. 1993; 13: 119–124
   PubMed Web of Science ®Google Scholar
• Dianzani F. Biological basis for the clinical use of interferon. Gut 1993; 34: S74–S76
   PubMed Web of Science ®Google Scholar
• Fantl V., Richards M. A., Smith R., Lammie G. A., Johnstone G., Allen D., Gregory W., Peters G., Dickson C., Barnes D. M. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur. J. Cancer 1990; 26: 423–429
   PubMed Web of Science ®Google Scholar
• Farrar M. A., Schreiber R. D. The molecular cell biology of interferongamma and its receptor. Ann. Rev. Immunol. 1993; 11: 571–611
   PubMed Web of Science ®Google Scholar
• Foulkes W. D., Black D. M., Stamp G. W., Solomon E., Trowsdale J. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int. J. Cancer 1993; 54: 220–225
   PubMed Web of Science ®Google Scholar
• Frye R. A., Benz C. C., Liu E. Detection of amplified oncogenes by polymerase chain reaction. Oncogene 1989; 4: 1153–1157
   PubMed Web of Science ®Google Scholar
• Gray P. E., Goeddel D. V. Structure of the human immune interferon gene. Nature 1982; 298: 859–863
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D., Neufeld G., Schweigerer L. Fibroblast growth factor: structural and biological properties. J. Cell. Physiol. 1987; 5: 15–26
   Google Scholar
• Henry J. A., Hennessy C., Levett D. L., Lennard T. W., Westly B. R., May F. E. int-2 amplification in breast cancer association with decreased survival and relationship to amplification of c-erb-B2 and c-myc. Int. J. Cancer 1993; 53: 774–780
   PubMed Web of Science ®Google Scholar
• Jaakola S., Salmikangas P., Nylund S., Partanen J., Armstrong E., Pyhonen S., Lehtovirta P., Nevanlinna H. Amplification of fgfr4 hene in human breast and gynecological cancers. Int. J. Cancer 1993; 54: 378–382
   PubMed Web of Science ®Google Scholar
• Jacobs I. J., Smith S. A., Wiseman R. W., Futreal P. A., Harrington T., Osborne R. J., Leech V., Molyneux A., Berchuck A., Ponder B. A. A deletion unit on chromosome 17q in epithelial ovarian tumours distal to the familial breast/ ovarian cancer locus. Cancer Res. 1993; 53: 1218–1221
   PubMed Web of Science ®Google Scholar
• Kihana T., Tsuda H., Teshima S., Nomoto K., Tsugane S., Sonoda T. Prognostic significance of over-expression of c-erb-B2 protn in adenocarcinoma of the uterine cervix. Cancer 1994; 73: 148–153
   PubMed Web of Science ®Google Scholar
• Kinoshita T., Imamura J., Nagai H., Shimotohno K. Quantification of gene expression over a wide range by the polymerase chain reaction. Anal. Biochem. 1992; 206: 231–235
   PubMed Web of Science ®Google Scholar
• Lonn U., Lonn S., Nylen U., Stenkvist B., Vennstrom B. Detection of temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction. Breast Cancer Res. Treat. 1992; 23: 191–200
   PubMed Web of Science ®Google Scholar
• Machotka S. V., Garrett C. T., Schwartz A. M., Callahan R. Amplification of the proto-oncogenes int-2, c-erb-B-2 and c-myc in human breast cancer. Clin. Chem. Acta. 1989; 184: 207–217
   PubMed Web of Science ®Google Scholar
• Moscatelli D., Quarto N. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin. J. Cell. Biol. 1989; 109: 2519–2527
   PubMed Web of Science ®Google Scholar
• Naylor S. L., Sakaguchi A. Y., Shows T. B., Law M. L., Goeddel D. V., Gray P. W. Human immune interferon gene is located on chromosome 12. J. Exp. Med. 1983; 157: 1020–1027
   PubMed Web of Science ®Google Scholar
• Neubauer A., Neubauer B., Liu E. Polymerase chain reaction based assay to detect allelic loss in human DNA; loss of β-interferon gene in chronic myelogeneous leukemia. Nucl. Acids Res. 1990; 18: 993–998
   PubMed Web of Science ®Google Scholar
• Noguchi M., Koyasaki N., Ohta N., Kitagawa H., Earashi M., Thomas M., Miyazaki I., Mizukami Y. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb-B2 expression in patients with breast cancer. Arch. Surg. 1993; 128: 242–246
   PubMedGoogle Scholar
• Peten E. P., Garcia-Perez A., Terada Y., Woodrow D., Martin B. M., Striker G. E., Striker L. J. Age-related changes in alpha 1- and alpha 2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR. Am. J. Physiol. 1992; 263: 951–957
   Google Scholar
• Phillips N., Ziegler M., Saha B., Xynos F. Allelic loss on chromosome 17 in human ovarian cancer. Int. J. Cancer 1993; 54: 85–91
   PubMed Web of Science ®Google Scholar
• Pidoux L., Hearn M. T. W. 1995, Unpublished results
   Google Scholar
• Radford D. M., Fair K., Thompson A. M., Ritter J. H., Holt M., Steinbrueck T., Wallace M., Wells S. A., Jr., Donis-Keller H. R. Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res. 1993; 53: 2947–2949
   PubMed Web of Science ®Google Scholar
• Rogelj S., Weinberg R. A., Fanning P., Klagsburn M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 1988; 331: 173–176
   PubMed Web of Science ®Google Scholar
• Rosen A., Sevelda P., Klein M., Dobianer K., Hruza C., Czerwenka K., Hanak H., Vavra H., Salzer H., Leodolters S. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br. J. Cancer 1993; 67: 1122–1125
   PubMed Web of Science ®Google Scholar
• Schmitt J. F., Guthridge M., Economou C., Bertolini J., Hearn M. T. W. A New Quantitative Polymerase Chain Reaction-High Performance Ion Exchange Liquid Chromatographic Method for the Detection of Fibroblast Growth Factor-β (FGF-β) Gene Amplification. J. Biochem. Biophys. Meth. 1991; 24: 119–133
   Google Scholar
• Slamon D. J., Clark C. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–182
   PubMed Web of Science ®Google Scholar
• Slamon D. J., Godolphin W., Jones L. A., Holt J. A., Wong S. G., Keith D. E., Levin W. J., Stuart S. G., Udove J., Ullrich A. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–712
   PubMed Web of Science ®Google Scholar
• Theillet C., Le Roy X., De Lapeyriere O., Grosgeorges J., Adnane J., Raynaud S. D., Simony-Lafontaine J., Goldfarb M., Escot C., Birnbaum D. Amplification of FGF-related genes in human tumours: Possible involvement of HST in breast carcinomas. Oncogene 1989; 4: 915–922
   PubMed Web of Science ®Google Scholar
• Tsuda H., Hirohashi S., Shimosato Y., Hirota T., Tsugane S., Yamamoto H., Miyajima N., Toyoshima K., Yamamoto T., Yokota J. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene co-amplification units: hst-1/int-2 and c-erbB-2/ ear-1. Cancer Res. 1989; 49: 3104–3108
   PubMed Web of Science ®Google Scholar
• Tsuda H., Tsugane S., Fukutomi T., Nanasawa T., Yamamoto H., Hirohashi S. Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erb-B2 proto-oncogene. Jpn. J. Clin. Oncol. 1992; 22: 244–249
   PubMed Web of Science ®Google Scholar
• Wynford-Thomas D. Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour. J. Pathol. 1991; 165: 187–201
   PubMed Web of Science ®Google Scholar
• Zhang X., Silva E., Gershehenson D., Hung M. C. Amplification and rearrangement of c-erb-B2 proto-oncogene in cancer of human genital tract. Oncogene 1989; 4: 985–989
   PubMed Web of Science ®Google Scholar
• Zhou D. J., Casey G., Cline M. J. Amplification of human int-2 in breast cancers and squamous carcinomas. Oncogene 1988; 2: 279–282
   PubMed Web of Science ®Google Scholar
• Zhou D. J., Ahuja H., Cline M. J. Proto-oncogene abnormalities in human breast cancer: c-erb-B2 amplification does not correlate with recurrence of the disease. Oncogene 1989; 4: 105–108
   PubMed Web of Science ®Google Scholar